£52.19

GEMCITABINE PHARMACOLOGY CLINICAL US: Pharmacology, Clinical Uses & Potential Side Effects (Pharmacology-Research, Safety Testing and Regulation)

Other Branches of Medicine

Price data checked 7 days ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

Cheaper than 60% of the days we've watched it. Below what most people pay.

£52 today · 30-day average £58 · all-time low £28

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 84 days • 84 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 84 days • 6 price levels

Days at Price

Current Price

Price Analysis

Most common price: £79 (23 days, 27.4%)

Price range: £28 - £79

Price levels: 6 different prices over 84 days

Description

Gemcitabine was synthesised in the 1980s at Lilly Research Laboratories (Eli Lilly and Co., Indianapolis, IN). It was initially developed as an antiviral agent, but it had an extremely narrow therapeutic index due to its cytotoxicity against the parental cell lines. As it presented wide activity against various solid tumors it was then evaluated as an anticancer drug. This pyrimidine antimetabolite was firstly approved in 1996 by the Food and Drug Administration (FDA) for the treatment of pancreatic cancer. It is currently used for the treatment of many other malignancies such as lung cancer, breast cancer, lymphoma, bladder cancer, mesothelioma and ovarian cancer. This book discusses the molecular pharmacology, and the pharmacogenetics of gemcitabine. It also discusses the antineoplastic mechanism of gemcitabine on tumour cells; the systemic adverse effects; and provides detail on the clinical uses gemcitabine has on breast cancer.

Product Specifications

Format: paperback
ASIN: 1633210111
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine
Domain: Amazon UK
Release Date: 01 September 2014
Listed Since: 18 April 2014

Barcode

No barcode data available

GEMCITABINE PHARMACOLOGY CLINICAL US: Pharmacology, Clinical Uses & Potential Side Effects (Pharmacology-Research, Safety Testing and Regulation)

Cheaper than 60% of the days we've watched it. Below what most people pay.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

The Chemistry of Antitumour Agents

Physicians' Cancer Chemotherapy Drug Manual 2015

The Oncogenomics Handbook (Cancer Drug Discovery and Development)

Cancer Chemotherapy: Basic Science to the Clinic

Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Clinical Guide to Antineoplastic Therapy: A Chemotherapy Handbook

HEMATOLOGY AND ONCOLOGY Handbook of Cancer Chemotherapy Protocols

The Bethesda Handbook of Clinical Oncology

Cancer: Principles and Practice of Oncology Primer of Molecular Biology in Cancer

Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy (Cancer Drug Discovery and Development)

Cancer Biology and Therapeutics

Cancer Biology and Therapeutics

Cancer Chemotherapy, Immunotherapy, and Biotherapy

Handbook of Cancer Treatment-Related Symptoms and Toxicities

Humana Anticancer Drug Development Guide - Oncology Textbook

Handbook of Targeted Cancer Therapy and Immunotherapy

Wiley Anticancer Therapeutics - Oncology Drug Design Book

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Oncologic Therapies

Small Molecules in Oncology: 211 (Recent Results in Cancer Research, 211)

Physicians' Cancer Chemotherapy Drug Manual 2025

Springer Cancer Chemotherapy: Concepts and Clinical Advances 42